JP Sommadossi said IDIX has hired 30-40 sales reps to sell Telbivudine in the U.S. and 75% of these reps are experienced in the HBV market, specifically.
I infer that IDIX has hired away some reps from GILD and BMY because there are few other places where sales reps experienced in HBV can be found.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”